
ãæ¥œåãã©ãªãšçްèã®å¥è·¡â£ã
ââ æ¥œåããã®èŽããã®ã5-ALAãšå ±ã«æ©ããæ°ãã现èã®æä»£ãž ââ
â»æ¬èšäºã¯ãæµ·å€ã§è¡ãããŠããç¹å®ã®æåã«é¢ããèšåºç ç©¶ããã³æ²»éšã®äºå®ã玹ä»ãããã®ã§ãããæ¥æ¬åœå ã«ãããç¹å®ã®ãµããªã¡ã³ãã®å¹æå¹èœãæšæŠã»ä¿èšŒãããã®ã§ã¯ãããŸããã
ãæ¥œåãã©ãªãšçްèã®å¥è·¡â¢ãã¯ãã¡ãã
â¶ïžã第3åãªã³ã¯ã
第1åããèªã¿ããæ¹ã¯ãã¡ãã
â¶ïžã第1åãªã³ã¯ã
â ã¯ããã«
å š4åã«ããã£ãŠãå±ãããŠãããæ¥œåãã©ãªãšçްèã®å¥è·¡ãããä»åãããããæçµåã§ãã
ãã©ãªãšããå°ããªå³¶åœããå§ãŸã£ããã®ç©èªã¯ããããããã£ãŠãç§ãã¡ã®çްèã®äžã«ãããçåœã®ç«ãã®ã話ã§ããããŸããã
æçµåãšãªãä»åã¯ããã®ã·ãªãŒãºå šäœãæ¯ãè¿ããªããã5-ALAãšããååã瀺ããæªæ¥ã®å¯èœæ§ããšãç§ãã¡ã仿¥ããã§ãã倧åãªéžæã«ã€ããŠãäŒãããŸãã
â â ãã®ã·ãªãŒãºã§æããã«ãªã£ãã4ã€ã®åãã
4åã«ããã£ãŠãç§ãã¡ã¯ä»¥äžã®åããäžç·ã«èããŠããŸããã
ãªããæ¥œåããªã¹ã¯ã«èãŸããã®ãïŒ
æ¥æ¿ãªé£ã®æ¬§ç±³åãšãæŽå²ã®ãªãã§è²ãŸãããå¹çŽéºäŒåããšã®ãã¹ããããç°å¢ã®å€åã«çްèã®ã·ã¹ãã ã远ãã€ããªãã£ããšããçŸä»£ã®èª²é¡ããªãããå€ããæã蟌ããã ãã§ã¯è¶³ããªãã®ãïŒ
å¥åº·ã®èª²é¡ã¯ããæº¢ãããã®ãå€ããåŠçãããåé¡ã§ã¯ãªããã现èããšãã«ã®ãŒãããŸãçãããããªããªã£ãããšãã代è¬å šäœã®ãã©ã³ã¹ã®ä¹±ããšããŠæãçŽããå§ããŠããŸãã5-ALAãšã¯äœè ãïŒ
æ€ç©ã®å åæãã人éã®ããã³ã³ããªã¢ãŸã§ãçåœã®ãšãã«ã®ãŒå€æã®æ ¹æ¬ãæ¯ããéèŠãªååãé·ãæéãè¶ ããŠåãç¶ããããçåœæŽ»åã®ããŒã¹ãšãªãååšã§ããç ç©¶è ãã¡ã¯äœãèŠæ®ããŠããã®ãïŒ
åãªãäžæçãªå¯Ÿçã«ãšã©ãŸãããå šèº«ã®ã³ã³ãã£ã·ã§ãã³ã°ãå¥åº·ç¶æããããŠå®å®å»åŠãŸã§ã倿§ãªåéãžãšåºãã5-ALAç ç©¶ã¯ãããã³ã³ããªã¢ãšãããçåœæŽ»åã®åºç€ãã«é¢ããååã ããããã®å¿ ç¶ã®åºããã§ãã
â â¡ ãã©ãªã®æµ·ãšã现èã®ãå ±éç¹ã
ããã§å°ããèŠéãåºãã話ããããŠãã ããã
ãã©ãªãäžçäžã®äººã ãé äºããæå€§ã®çç±ã®ã²ãšã€ããæ¯ãã®ãã»ã©çŸããççç€ïŒããããããïŒã§ããå®ã¯ççç€ã¯ãæµ·æŽçæ ç³»å šäœã®ãšãã«ã®ãŒåŸªç°ãæ¯ããäžå¿å°ãšããŠç¥ãããŠããŸããæµ·å šäœã®é¢ç©ã®ããã0.1%ããå ããªãã«ãããããããæµ·ã®çãç©ã®çŽ25%ãççç€ã«äŸåããŠçããŠããŸãã
ç§ãã¡ã®äœå ã«ããããã³ã³ããªã¢ãããŸã£ããåãæ§é ãããŠããŸãã
现èã®äžã®ããå°ããªååšã§ãããªãããç§ãã¡ã®çåœæŽ»åãæ¯ããèšå€§ãªãšãã«ã®ãŒã®ã»ãšãã©ãçã¿åºããŠããã
ãã©ãªãšããæ¥œåããççç€ãšãããæµ·ã®åŸªç°ããæ±ããªããã现èã®ããšãã«ã®ãŒåŸªç°ããèŠã€ããåœå®¶ãããžã§ã¯ããç«ã¡äžãããããã¯æ±ºããŠå¶ç¶ã§ã¯ãªããçåœã®åŸªç°ãšãã倧ããªèŠç¹ããèŠãã°ããšãŠãèªç¶ãªå¿ ç¶ã ã£ãã®ãããããŸããã
â â¢ æ¥æ¬çºã®æè¡ããäžçã®èª²é¡ã«å¿ãã
5-ALAã®ããã²ãšã€ã®éèŠãªåŽé¢ããäŒãããŸãã å®ã¯5-ALAã¯ãå¥åº·ç¶æã®æåãšããŠã ãã§ãªããåœå ã«ãããŠå»çå¿çšã®ç ç©¶ãæ·±ãé²ããããŠããæŽå²ããããŸãã
å é²å»çã®çŸå Žã«ããããå ç·ååŠããšåŒã°ããé åã§ã¯ãç¹å®ã®çµç¹ãèå¥ã»å¯èŠåããããã®æè¡ãšããŠ5-ALAãå¿çšãããŠããŸãã
ãåºãå»çã»ç§åŠåéã§ããã®æçšæ§ãç ç©¶ã»å¿çšãããŠããããšããäºå®ã¯ããã®ååã«å¯Ÿããç§åŠçä¿¡é Œã®åãã瀺ãèæ¯ã®ã²ãšã€ã§ãã
ãããŠããã®5-ALAã®å®å®çãªçç£ãå¯èœã«ããã®ããæ¥æ¬ãèªãã埮çç©çºé µæè¡ãã§ããã çŽè±ãå³åãšããè±ããªçºé µæåãäœçŸå¹Žãè²ãã§ããæ¥æ¬ã ãããããçåœã«äžå¯æ¬ ãªååããèªç¶ã®åãåããŠç²Ÿç·»ã«çã¿åºãæè¡ãçºå±ãããããšãã§ããããã®èªãã¹ãæè¡ããã£ãããããããã©ãªãšããåœå®¶ãããžã§ã¯ããæ¯ããããŒãããŒã·ãããžãšã€ãªãã£ãŠãã£ãã®ã§ãã
â ⣠5-ALAãç §ãããæªç¥ãªãå¯èœæ§ã
çŸåšããã£ãŠããããšã¯ã5-ALAã®å¯èœæ§ã®ã»ãã®äžéšã«éããªãã®ãããããŸãããç ç©¶è ãã¡ã泚ç®ããŠããé åã¯ãä»ãäžçäžã§åºããç¶ããŠããŸãã
èªç¥æ©èœãšçްèãšãã«ã®ãŒã®é¢é£ç ç©¶
ããã³ã³ããªã¢ã®ã³ã³ãã£ã·ã§ã³ãšã幎霢ãšãšãã«å€åããã³ã³ãã£ã·ã§ã³ãšã®é¢é£ãç ç©¶ãããŠããŸãã5-ALAãããã®é åã«ãããç 究察象ã®ã²ãšã€ãšããŠæ³šç®ãããŠãããä»åŸã®ç ç©¶ã®é²å±ãæåŸ ãããŠããŸãã
ãšã€ãžã³ã°ã±ã¢ãšããæåç·ïŒFrontierïŒ
è¿å¹Žãäžçäžã®ç§åŠè ã®éã§ãå¹Žéœ¢ã«æãã®ã§ã¯ãªãã现èããå¥ããã«éããã«ã¯ã©ããã¹ããããšããç ç©¶ãæ¥éã«é²ãã§ããŸãããã®äžå¿ã«ããã®ãããã³ã³ããªã¢æ©èœã®ç¶æã§ããã5-ALAããŸããã€ã³ããŒã³ã³ãã£ã·ã§ã³ãæŽããéµãšããŠå€§ããªé¢å¿ãå¯ããããŠããŸãã
蟲æ¥ã»æ€ç©ç§åŠãžã®å¿çš
5-ALAã¯æ€ç©ã®å åæãšãæ·±ãé¢ãã£ãŠããŸãããã®ãã蟲æ¥åéã§ã¯ãäœç©ã®çè²ããå³ããç°å¢ã«å¯Ÿããèæ§ãé«ããç ç©¶ãè¡ãããŠããŸãã 人éã®çްèãæ¯ããååããå°çèŠæš¡ã®è±ããªé£ææªæ¥ã«ãé¢ãããããããªããããã»ã©ã®åºãããããã®å°ããªååã¯ç§ããŠããã®ã§ãã
â †ã仿¥ããå§ãããããã®äžæ©
æåŸã«ããã®ã·ãªãŒãºã§åŠãã ããšããç§ãã¡ã®æ¥åžžã«èœãšã蟌ãããã®ã·ã³ãã«ãªèŠç¹ããäŒãããŸãã
é£ããèããå¿ èŠã¯ãããŸãããããã³ã³ããªã¢ãå¿å°ããåããããç°å¢ããå°ããã€æŽããŠããã ãã§ãã
é£äºã®éžæ çºé µé£åïŒå³åã»çŽè±ã»ã¬ã挬ãïŒãééãè²ã®æ¿ãéèãæèããã粟補ãããç³ãé žåããæ²¹ãæããããªãã
æ¥ã ã®çæŽ»ç¿æ £ æã®å ãæµŽã³ãŠã¹ã€ãããå ¥ãããçæéã§ãå¿å°ããäœãåãããç¡ç ã®è³ªãäœãã倧åã«ããã
è£çµŠãšããéžæè¢ çŸä»£ã®å¿ããé£ç掻ã ãã§ã¯è£ããããªãéšåã«å¯ŸããŠãã5-ALAããšããè£çµŠã®éžæè¢ãèããŠã¿ãã
äœãã倧åãªã®ã¯ãå¿å°ãããç¶ããããšãã§ããæ¥ã ã®å°ããªç©ã¿éãã¯ãç®ã«ã¯èŠããªããŠããããªãã®çްèç°å¢ãéãã«æ¯ããåå°ã«ãªã£ãŠããã®ãããããŸããã
â ⥠楜åããã®èŽããã®
ãã©ãªã®éæãªæµ·ã®åºã§ãççç€ãéãã«çæ ç³»ãæ¯ããŠããããã«ã ããªãã®çްèã®äžã§ããããã³ã³ããªã¢ã¯ä»ãã®ç¬éãéãã«ããããå匷ããçåœã®ç«ããçããç¶ããŠããŸãã
ãã®åãã¯ãçãŸãæã£ãäœè³ªã ãã§æ±ºãŸã£ãŠããŸããã®ã§ã¯ãããŸããã
ããªãã®ããã³ã³ããªã¢ã¯ã äœå幎ãäœäžå¹Žãšããæéãè¶ ããŠåãç¶ãããŠãããçåœã®ç«ãã§ãã
ãã©ãªãšããå°ããªæ¥œåããäžçã«åããŠçºä¿¡ããã¡ãã»ãŒãžã¯ããšãŠãã·ã³ãã«ã§ãã ã现èãå åŽããæ¯ããããšãããããäººãæ¬æ¥æã€åãæ¯ããåå°ã«ãªãã
ãã®å°ããªãããã©å倧ãªãçåœã®ç«ããã仿¥ããããªãã®æ¥åžžãžã
â ã·ãªãŒãºå®çµã«ããã£ãŠ
å š4åã«ããã£ãŠãæèªããã ããæ¬åœã«ããããšãããããŸããã ãã©ãªãšããé ãå³¶åœã®ç©èªããããªãèªèº«ã®çްèãžã®èå³ãšãæ¥ã ã®æãããã±ã¢ãžã®äžæ©ã€ãªããã°ããã以äžå¬ããããšã¯ãããŸããã
â¶ïž [第1åããèªã¿çŽãããæ¹ã¯ãã¡ãã第1åãªã³ã¯ã]
ð¡ ãã®åœå®¶ãããžã§ã¯ãã®æåããä»ããããªãã®æ¥åžžã«
ããããç ç©¶ã¯ããŸã çºå±éäžã®éšåãå€ããããŸããããããã现èã®ãšãã«ã®ãŒä»£è¬ããšããèŠç¹ããå¥åº·ãèŠçŽãæµãã¯ãäžçäžã§å°ããã€åºããå§ããŠããŸãã
â 5-ALAã詊ãããæ¹ãž

5-ALAãéžæè¢ãšããŠèããŠããæ¹ãžã
æ¬é£èŒã¯ã5-ALAã補é ã»è²©å£²ããKIYAN PHARMAã®å ¬åŒã¢ãã£ãªãšã€ãããŒãããŒãšããŠãã¡ãŒã«ãŒçŽçµã®ç¹èšã«ãŒãããçšæããŠããŸãã
æµéãä»ããªãå ¬åŒã«ãŒãã®ãããèªè éå®ã§1,500ååŒããèªåé©çšãããŸãã
åããªããã°ããããŠãããããã ãã®ããšã§ãã
â· ãŸã詊ããŠã¿ããæ¹ïŒååïŒ
â»ç¶ããããšãåæã«ããæ¹ã¯å®æããåŸã§ã
â· ç¶ããããšãåæã«èããæ¹ïŒå®æã»1ç®±ïŒ
â· è€æ°ã§ã®ç¶ç¶ãèããæ¹ïŒå®æã»2ç®±ïŒ
â»äžèšã®ãªã³ã¯ããé²ããšãKIYAN PHARMAå ¬åŒè²©å£²ããŒãžãžçŽæ¥é·ç§»ããèªåã§1,500ååŒããé©çšãããŸãã
ãåºå žã»åèæç®ã
Tanaka T. et al. "5-Aminolevulinic acid combined with sodium ferrous citrate ameliorates glucose tolerance via the enhancement of mitochondrial function." PLOS ONE, 2013.
Stummer W. et al. "Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma." The Lancet Oncology, 2006.
Sinclair D.A. "Lifespan: Why We Age and Why We Don't Have To." Atria Books, 2019.
Hotta Y. et al. "5-Aminolevulinic acid stimulates mitochondrial biogenesis." Journal of Plant Growth Regulation, 2011.
SBIããŒã«ãã£ã³ã°ã¹æ ªåŒäŒç€ŸïŒ5-ALAã«é¢ãããã©ãªå ±ååœã§ã®ç³å°¿ç èšåºç ç©¶ã»æ²»éšãªãªãŒã¹
#ãã©ãª #5ALA #ããã³ã³ããªã¢ #ãšãã«ã®ãŒä»£è¬ #现èã±ã¢ #å¥åº·å¯¿åœ #现èããå¥åº·ã« #äºé²å»ç #ãã€ãªãã¯ãããžãŒ #ããã³ã³ããªã¢ç¿æ £